Rivaroxaban CAS 366789-02-8: A Comprehensive Overview of its Chemical Properties and Pharmaceutical Applications
Discover the essential chemical details and therapeutic significance of Rivaroxaban, a key pharmaceutical compound.
Get a Quote & SampleProduct Core Value
Rivaroxaban
Rivaroxaban, identified by CAS number 366789-02-8, is a vital pharmaceutical compound known for its role as a direct inhibitor of Factor Xa. This characteristic makes it instrumental in the prevention and treatment of various thromboembolic diseases. Its chemical makeup, C19H18ClN3O5S, with a molecular weight of 435.88, underscores its complex pharmaceutical design.
- Understanding the mechanism of action for direct inhibitors of Factor Xa is crucial for pharmaceutical research.
- Sourcing reliable pharmaceutical intermediates from China suppliers ensures product quality.
- The prevention of thromboembolic diseases is a major focus in modern medicine, with compounds like Rivaroxaban playing a key role.
- Accurate Rivaroxaban molecular formula and weight data are essential for analytical method development.
Key Advantages
Potent Factor Xa Inhibition
Rivaroxaban exhibits potent inhibition of Factor Xa, with a reported Ki of 0.4 nM, making it highly effective in its anticoagulant function.
Oral Administration
The compound's suitability for oral administration offers significant convenience for patients, simplifying treatment regimens.
Versatile Solubility Profile
Its solubility in common solvents like chloroform, DMSO, water, and ethanol facilitates its use in various formulation and analytical processes.
Key Applications
Pharmaceutical Reference Standards
As a critical reference standard, Rivaroxaban supports accurate analytical method development and quality control in pharmaceutical manufacturing.
Research Chemicals
Its availability as a research chemical aids scientists in exploring new therapeutic applications and understanding its pharmacological effects.
Drug Development
The compound serves as a foundational element in the development of new anticoagulant therapies, contributing to advancements in cardiovascular medicine.
Chemical Synthesis Intermediate
Its well-defined chemical structure makes it a valuable intermediate in complex organic synthesis pathways within the fine chemical industry.